Contribution of Serum Leptin to Metabolic Syndrome in Obese and Nonobese Subjects

Archives of Medical Research

Volumn 42, Issue 3, 2011, Pages 244-251

  Esteghamati, Alireza ^a   Noshad, Sina ^a   Khalilzadeh, Omid ^a   Morteza, Afsaneh ^a   Nazeri, Arash ^a   Meysamie, Alipasha ^a   Esteghamati, Abdolreza ^a   Nakhjavani, Manuchehr ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BMI; International Diabetes Federation; Leptin; Metabolic syndrome; Obesity; Waist circumference

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CIGARETTE SMOKING; CLINICAL ASSESSMENT TOOL; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 79959722515     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.05.005     Document Type: Article

References (48)

1. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
2. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
3. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
4. Grundy S.M., Hansen B., Smith S.C., et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004, 109:551-556.
5. Grundy S.M., Brewer H.B., Cleeman J.I., et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
6. Ingelsson E., Larson M.G., Yin X., et al. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J Clin Endocrinol Metab 2008, 93:3149-3157.
7. Kelesidis T., Kelesidis I., Chou S., et al. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010, 152:93-100.
8. Farooqi I.S., O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009, 89:980S-984S.
9. Farooqi I.S., Matarese G., Lord G.M., et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002, 110:1093-1103.
10. Morris D.L., Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009, 297:E1247-1259.
11. Wannamethee S.G., Tchernova J., Whincup P., et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2007, 191:418-426.
12. Ho S.C., Tai E.S., Eng P.H., et al. A study in the relationships between leptin, insulin, and body fat in Asian subjects. Int J Obes Relat Metab Disord 1999, 23:246-252.
13. Chu N.F., Wang D.J., Shieh S.M., et al. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan-The Taipei Children Heart Study. Int J Obes Relat Metab Disord 2000, 24:1265-1271.
14. Haluzik M., Fiedler J., Nedvidkova J., et al. Serum leptin levels in patients with hyperlipidemias. Nutrition 2000, 16:429-433.
15. Lyoussi B., Ragala M.A., Mguil M., et al. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans. Clin Exp Hypertens 2005, 27:377-394.
16. Zeelie A., Moss S.J., Kruger H.S. The relationship between body composition and selected metabolic syndrome markers in black adolescents in South Africa: The PLAY study. Nutrition 2010, 26:1059-1064.
17. Schutte R., Huisman H.W., Schutte A.E., et al. Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity: the POWIRS study. J Hum Hypertens 2005, 19:535-541.
18. Yun J.E., Kimm H., Jo J., et al. Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations. Metabolism 2010, 59:424-429.
19. Lieb W., Sullivan L.M., Harris T.B., et al. Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care 2009, 32:612-616.
20. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295.
21. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
22. Haffner S.M., Gingerich R.L., Miettinen H., et al. Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes Relat Metab Disord 1996, 20:904-908.
23. Esteghamati A., Meysamie A., Khalilzadeh O., et al. Third National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 2009, 9:167.
24. Esteghamati A., Khalilzadeh O., Rashidi A., et al. Physical activity in Iran: results of the Third National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). J Phys Act Health 2011, 8:27-35.
25. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
26. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
27. Esteghamati A., Abbasi M., Rashidi A., et al. Optimal waist circumference cut-offs for the diagnosis of metabolic syndrome in Iranian adults: results of the Third National Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Diabet Med 2009, 26:745-746.
28. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(suppl 1):S62-69.
29. Hu F.B., Chen C., Wang B., et al. Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Int J Obes Relat Metab Disord 2001, 25:121-125.
30. Sheu W.H., Lee W.J., Chen Y.T. High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999, 17:1289-1295.
31. Kennedy A., Gettys T.W., Watson P., et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997, 82:1293-1300.
32. Jockenhovel F., Blum W.F., Vogel E., et al. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab 1997, 82:2510-2513.
33. Doucet E., St-Pierre S., Almeras N., et al. Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study. J Clin Endocrinol Metab 2000, 85:4231-4237.
34. Valle M., Martos R., Gascon F., et al. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 2005, 31:55-62.
35. Mendoza-Nunez V.M., Garcia-Sanchez A., Sanchez-Rodriguez M., et al. Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. Obes Res 2002, 10:253-259.
36. Leyva F., Godsland I.F., Ghatei M., et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998, 18:928-933.
37. Rainwater D.L., Comuzzie A.G., VandeBerg J.L., et al. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 1997, 132:237-243.
38. Franks P.W., Brage S., Luan J., et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res 2005, 13:1476-1484.
39. Ukkola O., Kesaniemi Y.A. Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects. Metabolism 2007, 56:1221-1227.
40. Galletti F., Barbato A., Versiero M., et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens 2007, 25:1671-1677.
41. Baratta M. Leptin-from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit 2002, 8:RA282-292.
42. Werner N., Nickenig G. From fat fighter to risk factor: the zigzag trek of leptin. Arterioscler Thromb Vasc Biol 2004, 24:7-9.
43. Sanchez-Margalet V., Martin-Romero C., Santos-Alvarez J., et al. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol 2003, 133:11-19.
44. Shek E.W., Brands M.W., Hall J.E. Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31:409-414.
45. Schwartz M.W., Baskin D.G., Bukowski T.R., et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996, 45:531-535.
46. Esteghamati A., Khalilzadeh O., Anvari M., et al. Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab Syndr Relat Disord 2009, 7:447-452.
47. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
48. Matarese G., Moschos S., Mantzoros C.S. Leptin in immunology. J Immunol 2005, 174:3137-3142.